Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CymaBay Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $31.97 | Feb 12, 2024 | Direct |
CymaBay Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | Mar 22, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CBAY | CymaBay Therapeutics, Inc. | Mar 22, 2024 | 4 | $0 | 4 | Mar 22, 2024 | Director |
CBAY | CymaBay Therapeutics, Inc. | Feb 12, 2024 | 3 | -$164K | 4 | Feb 14, 2024 | Director |
CBAY | CymaBay Therapeutics, Inc. | Jan 24, 2024 | 1 | $0 | 4 | Jan 26, 2024 | Director |
CBAY | CymaBay Therapeutics, Inc. | Jan 10, 2024 | 3 | -$115K | 4 | Jan 10, 2024 | Director |
CBAY | CymaBay Therapeutics, Inc. | Dec 11, 2023 | 3 | -$92.6K | 4 | Dec 11, 2023 | Director |
CBAY | CymaBay Therapeutics, Inc. | Nov 10, 2023 | 3 | -$74.3K | 4 | Nov 14, 2023 | Director |
CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2023 | 1 | $0 | 4 | Jan 27, 2023 | Director |
CBAY | CymaBay Therapeutics, Inc. | Jan 25, 2022 | 1 | $0 | 4 | Jan 27, 2022 | Director |